Roth....Rothschild
Wonder if there's any connection....has me wondering if Roth Capital LLC might have some role to play in a possible Naz listing. We all know Resverlogix is going to need to raise some cash to pay off their loan to 3rd Eye as well as to finance future trials in CKD and Fabry's, assuming they don't get bought out first.
In a recent post I remarked on my jaded view on the markets, and that industry players (like Roth) aren't likely to provide exposure to a company unless they have some skin in the game, which I do not believe Roth has at this particular time.
Could this initiation of coverage be a signal that they might be a player down the road? The company announced back on July 31st that Rothschild & Co had been engaged to assist the company in securing a US listing. Might Roth be involved in some way, perhaps underwriting a secondary to coincide with a listing on the Naz?
Something to think about anyway....interestingly the rating is 'moderate buy'. If Roth does get involved in a tangible way like by underwriting an offering, then there seems to be room to upgrade the rating.
News 
Market Data 
Discover 
